Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2007 (2007), Article ID 26839, 13 pages
http://dx.doi.org/10.1155/2007/26839
Research Article

Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling

1Nutrigenomics Consortium, Wageningen Centre for Food Sciences, P.O. BOX 557, Wageningen 6700 AN, The Netherlands
2Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, P.O. BOX 8129, Wageningen 6700 EV, The Netherlands
3Life Sciences Research Unit, University of Luxembourg, 162A Avenue de la Faïencerie, Luxembourg 1511, Luxembourg

Received 17 May 2007; Accepted 25 July 2007

Academic Editor: Michael L. Cunningham

Copyright © 2007 Maryam Rakhshandehroo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kersten, B. Desvergne, and W. Wahli, “Roles of PPARs in health and disease,” Nature, vol. 405, no. 6785, pp. 421–424, 2000. View at Publisher · View at Google Scholar
  2. R. M. Evans, G. D. Barish, and Y.-X. Wang, “PPARs and the complex journey to obesity,” Nature Medicine, vol. 10, no. 4, pp. 355–361, 2004. View at Publisher · View at Google Scholar
  3. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Publisher · View at Google Scholar
  4. V. Bocher, I. Pineda-Torra, J.-C. Fruchart, and B. Staels, “PPARs: transcription factors controlling lipid and lipoprotein metabolism,” Annals of the New York Academy of Sciences, vol. 967, pp. 7–18, 2002. View at Google Scholar
  5. S. A. Smith, “Peroxisomal proliferater-activated receptors and the regulation of lipid oxidation and adipogenesis,” Biochemical Society Transactions, vol. 25, no. 4, pp. 1242–1248, 1997. View at Google Scholar
  6. D. Ren, T. N. Collingwood, E. J. Rebar, A. P. Wolffe, and H. S. Camp, “PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis,” Genes & Development, vol. 16, no. 1, pp. 27–32, 2002. View at Publisher · View at Google Scholar
  7. E. D. Rosen, C.-H. Hsu, X. Wang et al., “C/EBPa induces adipogenesis through PPAR?: a unified pathway,” Genes & Development, vol. 16, no. 1, pp. 22–26, 2002. View at Publisher · View at Google Scholar
  8. E. D. Rosen and B. M. Spiegelman, “Molecular regulation of adipogenesis,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 145–171, 2000. View at Publisher · View at Google Scholar
  9. Y.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor d activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar
  10. Y.-X. Wang, C.-L. Zhang, R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPARd,” PLoS Biology, vol. 2, no. 10, p. e294, 2004. View at Publisher · View at Google Scholar
  11. M. D. Leibowitz, C. Fiévet, N. Hennuyer et al., “Activation of PPARd alters lipid metabolism in db/db mice,” FEBS Letters, vol. 473, no. 3, pp. 333–336, 2000. View at Publisher · View at Google Scholar
  12. N. Di-Poï, N. S. Tan, L. Michalik, W. Wahli, and B. Desvergne, “Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway,” Molecular Cell, vol. 10, no. 4, pp. 721–733, 2002. View at Publisher · View at Google Scholar
  13. D. Patsouris, S. Mandard, P. J. Voshol et al., “PPARa governs glycerol metabolism,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 94–103, 2004. View at Publisher · View at Google Scholar
  14. P. Gervois, R. Kleemann, A. Pilon et al., “Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-a activator fenofibrate,” Journal of Biological Chemistry, vol. 279, no. 16, pp. 16154–16160, 2004. View at Publisher · View at Google Scholar
  15. P. Delerive, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors in inflammation control,” Journal of Endocrinology, vol. 169, no. 3, pp. 453–459, 2001. View at Publisher · View at Google Scholar
  16. H. Moshage, A. Casini, and C. S. Lieber, “Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes,” Hepatology, vol. 12, no. 3, part 1, pp. 511–518, 1990. View at Publisher · View at Google Scholar
  17. C. L. Bevins, “The Paneth cell and the innate immune response,” Current Opinion in Gastroenterology, vol. 20, no. 6, pp. 572–580, 2004. View at Publisher · View at Google Scholar
  18. P. R. Devchand, A. K. Hihi, M. Perroud, W.-D. Schleuning, B. M. Spiegelman, and W. Wahli, “Chemical probes that differentially modulate peroxisome proliferator-activated receptor α and BLTR, nuclear and cell surface receptors for leukotriene B4,” Journal of Biological Chemistry, vol. 274, no. 33, pp. 23341–23348, 1999. View at Publisher · View at Google Scholar
  19. D. B. Allison, X. Cui, G. P. Page, and M. Sabripour, “Microarray data analysis: from disarray to consolidation and consensus,” Nature Reviews Genetics, vol. 7, no. 1, pp. 55–65, 2006. View at Publisher · View at Google Scholar
  20. D. D. Hong, Y. Takahashi, M. Kushiro, and T. Ide, “Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat,” Biochimica et Biophysica Acta, vol. 1635, no. 1, pp. 29–36, 2003. View at Publisher · View at Google Scholar
  21. M. J. Coon, “Cytochrome P450: nature's most versatile biological catalyst,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 1–25, 2005. View at Publisher · View at Google Scholar
  22. X. Liu, M. Milo, N. D. Lawrence, and M. Rattray, “A tractable probabilistic model for Affymetrix probe-level analysis across multiple chips,” Bioinformatics, vol. 21, no. 18, pp. 3637–3644, 2005. View at Publisher · View at Google Scholar
  23. M. Dai, P. Wang, A. D. Boyd et al., “Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data,” Nucleic Acids Research, vol. 33, no. 20, p. e175, 2005. View at Publisher · View at Google Scholar
  24. S. Mandard, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor α target genes,” Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393–416, 2004. View at Publisher · View at Google Scholar
  25. G. Haemmerle, R. Zimmermann, M. Hayn et al., “Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis,” Journal of Biological Chemistry, vol. 277, no. 7, pp. 4806–4815, 2002. View at Publisher · View at Google Scholar
  26. R. Zimmermann, J. G. Strauss, G. Haemmerle et al., “Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase,” Science, vol. 306, no. 5700, pp. 1383–1386, 2004. View at Publisher · View at Google Scholar
  27. G. Haemmerle, A. Lass, R. Zimmermann et al., “Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase,” Science, vol. 312, no. 5774, pp. 734–737, 2006. View at Publisher · View at Google Scholar
  28. T. Ishida, S. Choi, R. K. Kundu et al., “Endothelial lipase is a major determinant of HDL level,” Journal of Clinical Investigation, vol. 111, no. 3, pp. 347–355, 2003. View at Publisher · View at Google Scholar
  29. W. Jin, J. S. Millar, U. Broedl, J. M. Glick, and D. J. Rader, “Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo,” Journal of Clinical Investigation, vol. 111, no. 3, pp. 357–362, 2003. View at Publisher · View at Google Scholar
  30. U. C. Broedl, C. Maugeais, D. Marchadier, J. M. Glick, and D. J. Rader, “Effects of nonlipolytic ligand function of endothelial lipase on high density lipoprotein metabolism in vivo,” Journal of Biological Chemistry, vol. 278, no. 42, pp. 40688–40693, 2003. View at Publisher · View at Google Scholar
  31. F. E. Frerman, “Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase,” Biochemical Society Transactions, vol. 16, no. 3, pp. 416–418, 1988. View at Google Scholar
  32. J. D. Beckmann and F. E. Frerman, “Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver: purification and molecular, redox, and catalytic properties,” Biochemistry, vol. 24, no. 15, pp. 3913–3921, 1985. View at Publisher · View at Google Scholar
  33. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999. View at Google Scholar
  34. C. M. Jenkins, D. J. Mancuso, W. Yan, H. F. Sims, B. Gibson, and R. W. Gross, “Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities,” Journal of Biological Chemistry, vol. 279, no. 47, pp. 48968–48975, 2004. View at Publisher · View at Google Scholar
  35. T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7473–7478, 1999. View at Publisher · View at Google Scholar
  36. T. E. Akiyama, C. J. Nicol, C. Fievet et al., “Peroxisome proliferator-activated receptor-a regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 39088–39093, 2001. View at Publisher · View at Google Scholar
  37. G. Svegliati-Baroni, C. Candelaresi, S. Saccomanno et al., “A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-a and n-3 polyunsaturated fatty acid treatment on liver injury,” American Journal of Pathology, vol. 169, no. 3, pp. 846–860, 2006. View at Publisher · View at Google Scholar
  38. M. M. Haluzik, Z. Lacinova, M. Dolinkova et al., “Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-a agonist treatment is accompanied by paradoxical increase of circulating resistin levels,” Endocrinology, vol. 147, no. 9, pp. 4517–4524, 2006. View at Publisher · View at Google Scholar
  39. T. Nagasawa, Y. Inada, S. Nakano et al., “Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARd agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet,” European Journal of Pharmacology, vol. 536, no. 1-2, pp. 182–191, 2006. View at Publisher · View at Google Scholar
  40. Y. Harano, K. Yasui, T. Toyama et al., “Fenofibrate, a peroxisome proliferator-activated receptor a agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver,” Liver International, vol. 26, no. 5, pp. 613–620, 2006. View at Publisher · View at Google Scholar
  41. M. G. McCoy, G.-S. Sun, D. Marchadier, C. Maugeais, J. M. Glick, and D. J. Rader, “Characterization of the lipolytic activity of endothelial lipase,” Journal of Lipid Research, vol. 43, no. 6, pp. 921–929, 2002. View at Google Scholar
  42. M. K. Wu and D. E. Cohen, “Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice,” American Journal of Physiology, vol. 289, no. 3, pp. G456–G461, 2005. View at Publisher · View at Google Scholar
  43. J. S. Bodnar, A. Chatterjee, L. W. Castellani et al., “Positional cloning of the combined hyperlipidemia gene Hyplip1,” Nature Genetics, vol. 30, no. 1, pp. 110–116, 2002. View at Publisher · View at Google Scholar
  44. K. L. Donnelly, M. R. Margosian, S. S. Sheth, A. J. Lusis, and E. J. Parks, “Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip/ mice,” Journal of Nutrition, vol. 134, no. 6, pp. 1475–1480, 2004. View at Google Scholar
  45. S. S. Sheth, L. W. Castellani, S. Chari et al., “Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition,” Journal of Lipid Research, vol. 46, no. 1, pp. 123–134, 2005. View at Publisher · View at Google Scholar